XERS
Xeris Biopharma Holdings Inc
15.52%
$1.16 - $1.34
Feb 7th 2023 - Mar 21st 2023
Mar, 17, 2023
Two other drugs, each growing revenue steadily.
Mar, 13, 2023
That said, I fully expect continuing script and r... See more
Mar, 17, 2023
Two other drugs, each growing revenue steadily.
Mar, 13, 2023
That said, I fully expect continuing script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Feb, 24, 2023
There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.
Mar, 21, 2023
$FSR shows a strong growth in Revenue.
Mar, 21, 2023
Close to generating revenue is only positive
Mar, 21, 2023
$FSR Easy buy before revenue.
Mar, 20, 2023
$FSR shows a strong growth in Revenue.
Mar, 20, 2023
Looking at the last year, $FSR shows a very strong growth in Revenue.
Mar, 20, 2023
Looking at the last year, $FSR shows a very strong growth in Revenue.
Mar, 19, 2023
Revenue is expected to show an annual growth rate (CAGR 2023-2027) of 17.02%, resulting in a projected market volume of US$858.00bn by 2027. 🔥🍺
Mar, 18, 2023
$FSR: The Revenue has grown by 232.04% in the past year.
Mar, 18, 2023
$FSR: The Revenue has grown by 232.04% in the past year.
Mar, 17, 2023
Revenue and a profitable ocean program is coming.
Feb, 4, 2023
$TGTX shows a strong growth in Revenue.
Feb, 3, 2023
$TGTX shows a strong growth in Revenue.
Jan, 29, 2023
Add beginning revenue stream, BO rumors, a steady stream of upgrades.
Dec, 30, 2022
$TGTX This gonna be amazing guys after they sell their product Lets say 50.000 usd for the dose and they sell 500 a month Make the math and tell me how revenue they will get every quarter
Dec, 30, 2022
$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.
Dec, 30, 2022
This is not some get rich scheme, this is a solid biotech company with an approved product that will bring in billions in revenue.